Abstract
In gynecological cancer, sexual function plays an important role. Surgery affects female organs with consequences for sexual function beyond that of chemotherapy or radiotherapy. Premature menopause and loss of fertility may be especially important for younger patients. Also for elderly patients sexuality may be an important part of health-related quality of life. Therefore, we picture potential consequences of gynecological cancer therapy and how they may be prevented or addressed.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abbott-Anderson K, Kwekkeboom KL. A systematic review of sexual concerns reported by gynecological cancer survivors. Gynecol Oncol. 2012;124:477–89. Erratum in: Gynecol Oncol. 2012;126:501–8.
Lehmann V, Hagedoorn M, Tuinman MA. Body image in cancer survivors: a systematic review of case–control studies. J Cancer Surviv. 2015;9:339–48.
Brito LG, Pouwels NS, Einarsson JI. Sexual function after hysterectomy and myomectomy. Surg Technol Int. 2014;25:191–3.
Rodriguez-Wallberg KA, Oktay K. Fertility preservation during cancer treatment: clinical guidelines. Cancer Manag Res. 2014;6:105–17.
Höckel M, Horn LC, Fritsch H. Association between the mesenchymal compartment of uterovaginal organogenesis and local tumour spread in stage IB-IIB cervical carcinoma: a prospective study. Lancet Oncol. 2005;6:751–6.
Schover LR. Premature ovarian failure is a major risk factor for cancer-related sexual dysfunction. Cancer. 2014;120:2230–2.
Mørch LS, Løkkegaard E, Andreasen AH, et al. Hormone therapy and ovarian cancer. JAMA. 2009;302:298–305.
Hasenburg A, Gabriel B, Einig EM. Sexualität nach Therapie eines Ovarialkarzinoms. Geburtshilfe Frauenheilkd. 2008;68:1–4.
Eeles RA, Morden JP, Gore M, et al. Adjuvant hormone therapy may improve survival in epithelial ovarian cancer: results of the AHT randomized trial. J Clin Oncol. 2015;33:4138–44.
Donders G, Neven P, Moegele M, et al. Ultra-low-dose estriol and Lactobacillus acidophilus vaginal tablets (Gynoflor(®) for vaginal atrophy in postmenopausal breast cancer patients on aromatase inhibitors: pharmacokinetic, safety, and efficacy phase I clinical study. Breast Cancer Res Treat. 2014;145:371–9.
Johannesson L, Kvarnström N, Mölne J, et al. Uterus transplantation trial: 1-year outcome. Fertil Steril. 2015;103:199–204.
Bakker RM, ter Kuile MM, Vermeer WM, et al. Sexual rehabilitation after pelvic radiotherapy and vaginal dilator use: consensus using the Delphi method. Int J Gynecol Cancer. 2014;24:1499–506.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Hasenburg, A., Farthmann, J. (2017). Sexual Function After Gynaecological Cancer. In: Reisman, Y., Gianotten, W. (eds) Cancer, Intimacy and Sexuality. Springer, Cham. https://doi.org/10.1007/978-3-319-43193-2_16
Download citation
DOI: https://doi.org/10.1007/978-3-319-43193-2_16
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-43191-8
Online ISBN: 978-3-319-43193-2
eBook Packages: MedicineMedicine (R0)